We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The 2021 guidelines on the diagnosis of von Willebrand disease: A comparison with current clinical practice in Spanish centers.
- Authors
Álvarez‐Román, María Teresa; Sierra‐Aisa, Cristina; Jiménez‐Yuste, Víctor
- Abstract
The first three recommendations, based on the use of a validated bleeding assessment tool[7] (BAT) for diagnosis, endorsed this mechanism only for patients with a low probability of VWD (e.g., primary care [PC] setting). Keywords: 2021 guidelines; diagnosis; survey; von Willebrand disease; von Willebrand factor EN 2021 guidelines diagnosis survey von Willebrand disease von Willebrand factor 925 927 3 05/19/23 20230501 NES 230501 Von Willebrand disease (VWD) is the coagulopathy with more under-, over- and misdiagnosis due to its challenging diagnosis.[1] To improve care for people with VWD, in 2021 the American Society of Haematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Haemophilia Foundation (NHF) and the World Federation of Haemophilia (WFH) published guidelines on the diagnosis[2] and management[3] of VWD. On the other hand, in the case of a patient with a normal bleeding scale result or no assessment scales performed in the centre, 71% of the specialist would not expand the patient study to rule out VWD, while the remaining 29% would directly perform blood laboratory tests.
- Subjects
VON Willebrand disease; MEDICAL personnel; DIAGNOSIS; VON Willebrand factor
- Publication
Haemophilia, 2023, Vol 29, Issue 3, p925
- ISSN
1351-8216
- Publication type
Article
- DOI
10.1111/hae.14778